Tyrosine kinase inhibitors in HER2-positive breast cancer brain metastases: A systematic review and meta-analysis.

Yu, Yushuai; Huang, Kaiyan; Lin, Yuxiang; Zhang, Jie; Song, Chuangui

Yu, Yushuai; Huang, Kaiyan; Lin, Yuxiang; Zhang, Jie; Song, Chuangui.

Affiliation

Yu Y; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Huang K; Breast Cancer Institute, Fujian Medical University, Fuzhou, China.
Lin Y; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
Zhang J; Breast Cancer Institute, Fujian Medical University, Fuzhou, China.
Song C; Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

Cancer Med ; 12(14): 15090-15100, 2023 07.

Article de En | MEDLINE | ID: mdl-37255389

Sujet(s)
Mots clés

Brain metastases; HER2-positive; breast cancer; meta-analysis; small-molecule tyrosine kinase inhibitors

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du cerveau / Tumeurs du sein Type d'étude: Prognostic_studies / Systematic_reviews Limites: Female / Humans Langue: En Journal: Cancer Med Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google